Poster No:
477
Submission Type:
Abstract Submission
Authors:
Carina Koeppel*1, Josefin Mücke*2, Sofia Attolini1, Julia Wildschut1, Malek Bajbouj1, Simone Grimm3
Institutions:
1Charité Universitätsmedizin, Berlin, 2Universität Konstanz, Baden Württemberg, 3Medical School, Berlin
First Author:
Co-Author(s):
Introduction:
Postpartum depression (PPD) is one of the most prevalent postpartum complications with severe adverse effects for both the parent and the offspring. PPD impairs maternal quality of life, mother-infant bonding as well as the offspring's physical and emotional development (Slomian et al., 2019; Vogel et al., 2024). Hormonal transition periods such as pregnancy and postpartum are critical for the development of affective symptoms and closely linked to reductions in hippocampal volume observable up to two years postpartum (Pritschet et al., 2024). Having a unique function in mood regulation, memory encoding and adult neurogenesis, the observed alterations might reflect physiological neuroplasticity in the maternal brain, which is potentially dysregulated in postpartum depression (Cárdenas et al., 2020). However, studies in postpartum depressed mothers focusing on associations between structural markers and disease outcome remain scarce. Hence, in the present study, we aimed to investigate if hippocampal volume predicts treatment response in postpartum depression.
Methods:
To address this research question, clinical data was retrospectively collected from 18 mothers suffering from postpartum depression, admitted for in-patient treatment over 8-10 weeks to the psychiatric parent-child unit at Charité Berlin. Depression severity was weekly assessed via the Montgomery–Åsberg Depression Rating Scale (MADRS; Montgomery & Asberg, 1979) and every patient received a structural MRI at admission. Treatment response was defined as a reduction in total MADRS score from admission to discharge of fifty percent or more or a total MADRS score at discharge smaller or equal to ten (Hawley et al., 2002). The percentual change of the MADRS score from admission to discharge for each subject was calculated as a continuous measure of overall symptom reduction. Left and right hippocampus were defined as ROIs and segmented using the FSL pipeline fsl_anat, the volumes extracted using the fslstats command. Linear regression analyses were performed with percentual change in MADRS score as outcome variable and either left or right hippocampal volume as predictor, and TIV and depression severity as control variables. For all tests the alpha level was set to .05, statistical analysis was performed using R version 4.3.1.
Results:
Over the course of in-patient treatment, the mothers showed an average overall symptom reduction of 57.86% (SD = 20.35, range from 23.68 to 100%). The right hippocampus volume was significantly lower in the responders (M = 3650.02, SD = 269.32) than in the non-responders group (M = 4014.96, SD = 376.78), t(16)=2.40, p = .029. The model with left hippocampal volume as predictor for overall symptom reduction did not reach significance (F(1, 16) = 0.80, p = .386), while the model including the right hippocampal volume as predictor yielded statistical significance and explained 24.86% of the variance in overall symptom reduction in our sample (F(1, 16) = 5.29, p = .035, R² = .2486), Fig. 1.
Conclusions:
Our findings introduce first insights into structural markers for treatment response in postpartum depression with smaller hippocampal volume predicting better treatment outcomes. In line with neuroplastic changes observed over the course of the menstrual cycle, pregnancy and postpartum, our work further highlights the key role of the hippocampal structure in understanding the underlying mechanisms of affective disorders occurring in specific hormonal transition periods. Prospectively, structural markers may help provide more precise and personalized treatment strategies.
Disorders of the Nervous System:
Psychiatric (eg. Depression, Anxiety, Schizophrenia) 1
Novel Imaging Acquisition Methods:
Anatomical MRI 2
Keywords:
Affective Disorders
MRI
Psychiatric
Psychiatric Disorders
1|2Indicates the priority used for review
By submitting your proposal, you grant permission for the Organization for Human Brain Mapping (OHBM) to distribute your work in any format, including video, audio print and electronic text through OHBM OnDemand, social media channels, the OHBM website, or other electronic publications and media.
I accept
The Open Science Special Interest Group (OSSIG) is introducing a reproducibility challenge for OHBM 2025. This new initiative aims to enhance the reproducibility of scientific results and foster collaborations between labs. Teams will consist of a “source” party and a “reproducing” party, and will be evaluated on the success of their replication, the openness of the source work, and additional deliverables. Click here for more information.
Propose your OHBM abstract(s) as source work for future OHBM meetings by selecting one of the following options:
I do not want to participate in the reproducibility challenge.
Please indicate below if your study was a "resting state" or "task-activation” study.
Other
Healthy subjects only or patients (note that patient studies may also involve healthy subjects):
Patients
Was this research conducted in the United States?
No
Were any human subjects research approved by the relevant Institutional Review Board or ethics panel?
NOTE: Any human subjects studies without IRB approval will be automatically rejected.
Yes
Were any animal research approved by the relevant IACUC or other animal research panel?
NOTE: Any animal studies without IACUC approval will be automatically rejected.
Not applicable
Please indicate which methods were used in your research:
Structural MRI
For human MRI, what field strength scanner do you use?
1.5T
Which processing packages did you use for your study?
FSL
Provide references using APA citation style.
Cárdenas, E. F., Kujawa, A., & Humphreys, K. L. (2020). Neurobiological changes during the
peripartum period: Implications for health and behavior. Social Cognitive and
Affective Neuroscience, 15(10), 1097–1110. https://doi.org/10.1093/scan/nsz091
Hawley, C. J., Gale, T. M., & Sivakumaran, T. (2002). Defining remission by cut off score on
the MADRS: Selecting the optimal value. Journal of Affective Disorders, 72(2), 177–184. https://doi.org/10.1016/S0165-0327(01)00451-7
Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. The British journal of psychiatry : the journal of mental science, 134, 382–389. https://doi.org/10.1192/bjp.134.4.382
Pritschet, L., Taylor, C. M., Cossio, D., Faskowitz, J., Santander, T., Handwerker, D. A., ... & Jacobs, E. G. (2024). Neuroanatomical changes observed over the course of a human pregnancy. Nature Neuroscience, 1-8.
Slomian, J., Honvo, G., Emonts, P., Reginster, J. Y., & Bruyère, O. (2019). Consequences of maternal postpartum depression: A systematic review of maternal and infant outcomes. Women's health (London, England), 15, 1745506519844044. https://doi.org/10.1177/1745506519844044
Vogel, J. P., Jung, J., Lavin, T., Simpson, G., Kluwgant, D., Abalos, E., Diaz, V., Downe, S.,
Filippi, V., Gallos, I., Galadanci, H., Katageri, G., Homer, C. S. E., Hofmeyr, G. J., Liabsuetrakul, T., Morhason-Bello, I. O., Osoti, A., Souza, J. P., Thakar, R., … Oladapo, O. T. (2024). Neglected medium-term and long-term consequences of labour and childbirth: A systematic analysis of the burden, recommended practices, and a way forward. The Lancet Global Health, 12(2), e317-e330. https://doi.org/10.1016/S2214-109X(23)00454-0
No